Relief Therapeutics Holding AG (RLF.SW) - Stock Prices, Stock Peers & Analysis

Home
RLF.SW

Company Name	Relief Therapeutics Holding AG
Symbol	RLF.SW
Currency	CHF
Price	2.85
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	35,841,321
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.65 - 7.6
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Jack Weinstein M.B.A.
Website	https://www.relieftherapeutics.com

An error occurred while fetching data.

About Relief Therapeutics Holding AG

Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or